6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Sleep Disturbances in Substance Users
Sleep disturbances are a common and debilitating issue among individuals with substance use disorders. Substances like alcohol, stimulants, and opioids disrupt natural sleep patterns, leading to insomnia, fragmented sleep, or hypersomnia. Prolonged substance use alters the brain's circadian rhythms and sleep architecture, often exacerbating mental health challenges such as anxiety and depression. Addressing sleep disturbances is a critical component of recovery, as poor sleep can increase the risk of relapse. Behavioral interventions like sleep hygiene education and cognitive-behavioral therapy for insomnia (CBT-I) are effective in restoring healthy sleep. Medications, such as melatonin agonists or sedating antidepressants, may also be considered. Treating sleep issues alongside addiction fosters better overall recovery outcomes.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States